TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway

Qiao Liu1, Lei Xie1,2,3,4

  • 1Department of Computer Science, Hunter College, The City University of New York, New York, United States of America.

Plos Computational Biology
|February 12, 2021
PubMed

Insights

We developed TranSynergy, a deep learning model that predicts synergistic drug combinations for cancer treatment. It incorporates biological knowledge for improved accuracy and interpretability, aiding precision medicine and new therapy discovery.

Area of Science:

  • Computational biology
  • Machine learning in oncology
  • Drug discovery and development

Background:

  • Drug combinations offer improved cancer therapeutic efficacy and reduced resistance.
  • Experimental screening of all potential anti-cancer drug combinations is costly and time-consuming.
  • Current machine learning models for synergistic drug prediction face limitations in performance, biological knowledge integration, and interpretability.

Purpose of the Study:

  • To develop an advanced deep learning model for predicting synergistic drug combinations.
  • To enhance the performance and interpretability of synergistic drug combination prediction.
  • To integrate biological knowledge and mechanism-driven insights into predictive models.

Main Methods:

  • Developed TranSynergy, a knowledge-enabled, self-attention transformer-boosted deep learning model.
  • Incorporated cellular effects via cell-line gene dependency, gene-gene interactions, and drug-target interactions.
  • Introduced Shapley Additive Gene Set Enrichment Analysis (SA-GSEA) for gene contribution deconvolution and interpretability.

Main Results:

  • TranSynergy significantly outperforms state-of-the-art methods in synergistic drug combination prediction.
  • The model successfully identified novel pathways associated with synergistic combinations, supported by experimental evidence.
  • High-confidence synergistic drug combinations were predicted for ovarian cancer.

Conclusions:

  • Mechanism-driven machine learning, as exemplified by TranSynergy, shows significant potential in advancing cancer drug discovery.
  • The model's interpretability offers new insights for identifying precision medicine biomarkers and novel anti-cancer therapies.
  • TranSynergy provides a powerful computational tool for efficient drug combination screening, particularly for challenging cancers like ovarian cancer.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.9K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
9.2K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.5K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
771
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K